2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Basal Cell
4
Skin Neoplasms
2
Melanoma
2
Margins of Excision
2
Barrett Esophagus
2
Urologic Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Lesion
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Nevus, Pigmented
1
Nephrolithiasis
1
Multicystic renal dysplasia, bilateral
1
Lung Neoplasms
1
Lung Diseases
1
Hematuria
1
Esophageal Neoplasms
1
Carcinoma, Squamous Cell
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Benign Neoplasm of Liver and/or Biliary Ducts
1
Adenocarcinoma
1
Interventions
Oxaliplatin
46
Gemcitabine
45
Fluorouracil
40
Capecitabine
31
pembrolizumab
30
Leucovorin
29
Docetaxel
27
Cisplatin
25
Paclitaxel
23
Irinotecan
18
Carboplatin
18
Bevacizumab
18
130-nm albumin-bound paclitaxel
17
Radiotherapy
16
Pemetrexed
15
Albumin-Bound Paclitaxel
15
Nivolumab
13
Ramucirumab
11
Cyclophosphamide
11
Drug Therapy
9
Trastuzumab
8
Erlotinib Hydrochloride
8
zolbetuximab
7
Taxes
7
Radiosurgery
7
trastuzumab deruxtecan
6
cemiplimab
6
Blood Specimen Collection
6
regorafenib
5
durvalumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Microscopy, Confocal
×
Clear all
NCT07541911
2026-05-18
LaserSAFE
University College, London
Phase NA
Recruiting
693 enrolled